Resmed Announces Agreement to Sell MatrixCare Business
Resmed announced a definitive agreement to sell its MatrixCare business to private equity firm Frazier Healthcare Partners to sharpen its focus on sleep and breathing health. The divestiture excludes Resmed's other software businesses, Brightree and MEDIFOX DAN, and is expected to close in Q1 of fiscal year 2027.
Key figures
- Providers supported
- more than 15,000
- Frazier capital raised
- $11 billion
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.